Information  X 
Enter a valid email address

Ixico PLC ORD 1P (IXI)

Related News

25-May-2021 08:56 AM

Ixico profit rises in H1 on new business wins

AI data analytics company Ixico reported a rise in first-half profit as revenue was boosted by new business wins. For the six months ended 31 March 2021, pre-tax profit rose to £635 million from £493 million year-on-ear as revenue grew 8% to
26-Apr-2021 08:01 AM

Ixico sees higher revenue in H1 following new business wins

Data analytics company Ixico said it expected to report higher first-half revenue thanks to new business wins. Revenues were expected to be £4.9 million for six months to 31 March 2021, up 8% from £4.6 million for same period last year. T
19-Oct-2020 08:30 AM

Ixico reports jump in annual earnings, revenue; confirms 2021 outlook

Data analytics company Ixico said core earnings had doubled and would be at least in line with market expectations for the full year following a jump revenue. For the year ended 30 September 2020, earnings before interest, tax, depreciation, and amortis
24-Jun-2020 08:04 AM

Ixico expects to maintain double-digit revenue growth amid 'modest' Covid-19 impact

Data analytics company Ixico said it expected to maintain double-digit revenue growth across 2021 and confirmed that the impact of Covid-19 on the business had been 'modest.' The company said it was 'confident of achieving at least £
20-Apr-2020 09:20 AM

Ixico sees half-yearly revenue growing by a third

Data analytics company Ixico said it expected revenue to grow by a third in the first half of the year amid ongoing momentum. For the six months ended 31 March 2020, revenues were expected to grow by 33% to £4.6m on-year. At 31 March, the company
14-Apr-2020 07:34 AM

Ixico warns on revenue; wins £10.5m contract for Huntington's disease study

Data analytics company Ixico warned it expected a slowdown in revenues in the second half of the financial year amid customer delays to new projects in the wake of the going Covid-19 pandemic. Ongoing work on clinical trial projects was necessarily defer
04-Dec-2019 07:23 AM

Ixico swings to profit as revenue boosted by increasing portfolio of clinical trial projects

Data analytics company Ixico swung to an annual profit as an increasing portfolio of clinical trial projects boosted services revenue. For the year ended September 30, the company reported a pre-tax profit of £366K compared with a loss of £7
22-Nov-2019 08:12 AM

IXICO schedules full year results

IXICO, the AI data analytics company delivering insights in neuroscience, will announce its final results for the year ended 30 September 2019 on 4 December 2019. At 8:12am: (LON:IXI) IXICO plc share price was 0p at 70.5p Story provided by StockMarke
15-Oct-2019 09:18 AM

Ixico expects to top guidance, deliver first full-year of positive earnings

Ixico said it expected top guidance and deliver its first full-year of positive earnings since going public thanks to accelerated revenue growth. For the year ended 30 September 2019, revenue increased by 40% to £7.6m from a year earlier, with an
19-Aug-2019 07:53 AM

Ixico expects full-year revenue, earnings 'materially' ahead of expectations

Data analytics company Ixico said it expected full-year revenue and earnings to be 'materially' ahead of market expectations amid strong growth in the second half of the year. 'Given the performance in the period to date, the Board anti
07-Feb-2019 08:49 AM

Ixico appoints Grant Nash as Chief Financial Officer

Data analytics company Ixico on Thursday appointed Grant Nash as Chief Financial Officer. Mr Nash would take up the role on 29 April. He joined IXICO from the UK Biobank, a national and international health research data resource, where he had been Fina
11-Dec-2018 08:40 AM

Ixico CFO Susan Lowther resigns

Ixico said Tuesday that Susan Lowther had resigned from her position as Chief Financial Officer to pursue other business interests. Until a successor is appointed, Conor Wolfson, who had been with the company for over four years as the Group's Fina
04-Dec-2018 09:00 AM

Ixico slashes losses as revenue swells to record

Data analytics company Ixico said Tuesday annual losses more than halved supported by strong revenue in its core imaging business. For the year ended 30 September 2018, pre-tax losses narrowed to £0.793m from £1.91bn a year earlier and reven
21-Aug-2018 09:01 AM

Ixico sees full-year performance above market expectations as revenue to jump 24%

Data science company Ixico said Tuesday it expected to report full-year performance ahead of market expectations. This upbeat outlook arrived as the company forecast reported revenue for the full-year to be at least £5.1m, an increase of 24% from
23-May-2018 10:19 AM

Ixico halves first-half losses as revenue rises 30%

Digital technologies group Ixico operating losses more than halved in the six months to the end of March as revenue and margins grew. Operating losses after tax was £0.3m in the period, compared with a loss of £0.7m the same period a year ag
04-Apr-2018 07:35 AM

IXICO secures contract extension for advanced imaging clinical trial services

IXICO said Wednesday it has signed an extension to an existing contract with a top 15 global pharmaceutical company for advanced imaging clinical trial services in a neurodegenerative disease, progressive supranuclear palsy. The firm said the total contr
11-Dec-2017 07:18 AM

IXICO sees robust revenue growth

IXICO saw robust revenue growth in the year to the end of September strengthened by the entry into a number of new commercial contracts in a broad range of neurological diseases. The group said the results represented a positive first step on its path t
16-Nov-2017 08:20 AM

IXICO wins contract to deploy biosensors in clinical trial

IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activity sensors ('wearable biosensors') in a late stage trial for a psychiatric disorder. IXICO said the contract had a value aro
19-Oct-2017 02:03 PM

IXICO set to exceed expectations

IXICO has reported revenue for the year ended 30 September of £3.7m (2016: £3.1m). The Company said the £0.6m increase over the prior year reflects traction in the its commercially led organic growth strategy focused on the global bioph
04-Oct-2017 07:49 AM

IXICO wins new contract to support clinical trial

IXICO has signed a new contract, with a top 15 global pharmaceutical company, utilising wrist worn activity sensors ('wearable biosensors') in a phase II clinical trial for a neurological disorder. IXICO said this was its first commercial agre
25-Sep-2017 08:21 AM

IXICO wins contract with biopharmaceutical company

IXICO, the digital technologies company serving neuroscience, has signed a new contract with a North American based biopharmaceutical company worth £1.2m over a three-year term. IXICO said it would provide its technology enabled imaging services in
05-Sep-2017 07:56 AM

IXICO five-year contract extended

IXICO has signed an extension and expansion to its largest existing contract, which was awarded in August 2015, for a phase II/III clinical trial contract in Alzheimer's Disease. It said the total contract value had increased from US$6.8m to US$7.
24-Jul-2017 07:33 AM

IXICO expands collaboration with Biogen

IXICO, the digital technologies company serving neuroscience, has expanded its pilot of the Assessa PML platform which includes Biogen, a leading company in Multiple Sclerosis, and expert reading institutions. The Assessa PML digital platform is being p
05-Jul-2017 07:46 AM

IXICO wins contract for imaging clinical trial services

IXICO has signed a new contract for specialist imaging clinical trial services. It said the contract was for a phase II clinical trial of patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD). It said the study - sponso
22-May-2017 07:24 AM

IXICO losses narrow

Operating losses at IXICO - the digital technologies company serving neuroscience - narrowed to £0.8m in the six months to the end of March from £1.1m last time. Revenue increased by 31% to £2.0m and gross profit margins rose to 56% (20

a d v e r t i s e m e n t